ORIC PHARMACEUTICALS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
ORIC PHARMACEUTICALS, INC. (ORIC) reported Increase (Decrease) in Prepaid Expense and Other Assets of $658.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-03
- ORIC PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$21.00K, a 103.95% decline year-over-year.
- ORIC PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $679.00K, a 18.09% increase year-over-year.
- ORIC PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$2.11M.
- ORIC PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$782.00K.
- ORIC PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$1.79M.
- ORIC PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$143.00K.
- ORIC PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$1.62M.
- ORIC PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$1.03M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $658.00K 10-Q · filed 2026-08-03 | -$1.45M derived: sum of 3 quarters · filed 2026-08-03 | -$2.24M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $679.00K 10-Q · filed 2026-05-04 | -$1.43M derived: sum of 2 quarters · filed 2026-05-04 | -$2.21M derived: sum of 3 quarters · filed 2026-05-04 | -$1.68M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | -$2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$2.89M derived: sum of 2 quarters · filed 2026-02-23 | -$2.36M derived: sum of 3 quarters · filed 2026-08-03 | -$1.79M 10-K · filed 2026-02-23 |
| 2025-09-30 | -$782.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$250.00K derived: sum of 2 quarters · filed 2026-08-03 | $325.00K 10-Q · filed 2025-11-13 | -$1.03M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $532.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $1.11M 10-Q · filed 2026-08-03 | -$247.00K derived: sum of 3 quarters · filed 2026-08-03 | -$1.88M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $575.00K 10-Q · filed 2026-05-04 | -$779.00K derived: sum of 2 quarters · filed 2026-05-04 | -$2.41M derived: sum of 3 quarters · filed 2026-05-04 | -$1.98M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | -$1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$2.99M derived: sum of 2 quarters · filed 2026-02-23 | -$2.55M derived: sum of 3 quarters · filed 2026-02-23 | -$143.00K 10-K · filed 2026-02-23 |
| 2024-09-30 | -$1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.20M derived: sum of 2 quarters · filed 2025-11-13 | $1.21M 10-Q · filed 2025-11-13 | $206.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $434.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $2.84M 10-Q · filed 2025-08-12 | $1.84M derived: sum of 3 quarters · filed 2025-08-12 | $2.12M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $2.41M 10-Q · filed 2025-05-05 | $1.40M derived: sum of 2 quarters · filed 2025-05-05 | $1.68M derived: sum of 3 quarters · filed 2025-05-05 | $1.89M derived: sum of 4 quarters · filed 2025-05-05 |
| 2023-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | -$728.00K derived: sum of 2 quarters · filed 2025-02-18 | -$517.00K derived: sum of 3 quarters · filed 2025-02-18 | -$1.62M 10-K · filed 2025-02-18 |
| 2023-09-30 | $277.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $488.00K derived: sum of 2 quarters · filed 2024-11-12 | -$615.00K 10-Q · filed 2024-11-12 | -$1.89M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $211.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$892.00K 10-Q · filed 2024-08-12 | -$2.17M derived: sum of 3 quarters · filed 2024-08-12 | -$4.03M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$1.10M 10-Q · filed 2024-05-06 | -$2.38M derived: sum of 2 quarters · filed 2024-05-06 | -$4.25M derived: sum of 3 quarters · filed 2024-05-06 | -$2.67M derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | -$1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | -$3.14M derived: sum of 2 quarters · filed 2024-03-11 | -$1.57M derived: sum of 3 quarters · filed 2024-03-11 | -$1.03M 10-K · filed 2024-03-11 |
| 2022-09-30 | -$1.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$289.00K derived: sum of 2 quarters · filed 2023-11-06 | $247.00K 10-Q · filed 2023-11-06 | $115.00K derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | $1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $2.11M 10-Q · filed 2023-08-10 | $1.98M derived: sum of 3 quarters · filed 2023-08-10 | $1.28M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $536.00K 10-Q · filed 2023-05-08 | $404.00K derived: sum of 2 quarters · filed 2023-05-08 | -$299.00K derived: sum of 3 quarters · filed 2023-05-08 | $826.00K derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | -$132.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$835.00K derived: sum of 2 quarters · filed 2023-03-16 | $290.00K derived: sum of 3 quarters · filed 2023-03-16 | -$1.14M 10-K · filed 2023-03-16 |
| 2021-09-30 | -$703.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $422.00K derived: sum of 2 quarters · filed 2022-11-07 | -$1.01M 10-Q · filed 2022-11-07 | -$351.00K derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$307.00K 10-Q · filed 2022-08-11 | $352.00K derived: sum of 3 quarters · filed 2022-08-11 | $205.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$1.43M 10-Q · filed 2022-05-09 | -$773.00K derived: sum of 2 quarters · filed 2022-05-09 | -$920.00K derived: sum of 3 quarters · filed 2022-05-09 | $879.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $659.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $512.00K derived: sum of 2 quarters · filed 2022-03-21 | $2.31M derived: sum of 3 quarters · filed 2022-03-21 | $2.26M 10-K · filed 2022-03-21 |
| 2020-09-30 | -$147.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $1.65M derived: sum of 2 quarters · filed 2021-11-08 | $1.60M 10-Q · filed 2021-11-08 | $1.59M derived: sum of 4 quarters · filed 2022-03-21 |
| 2020-06-30 | $1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $1.75M 10-Q · filed 2021-08-10 | $1.74M derived: sum of 3 quarters · filed 2022-03-21 | $1.38M derived: sum of 4 quarters · filed 2022-03-21 |
| 2020-03-31 | -$53.00K 10-Q · filed 2021-05-06 | -$64.00K derived: sum of 2 quarters · filed 2022-03-21 | -$416.00K derived: sum of 3 quarters · filed 2022-03-21 | -$576.00K derived: sum of 4 quarters · filed 2022-03-21 |
| 2019-12-31 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | -$363.00K derived: sum of 2 quarters · filed 2022-03-21 | -$523.00K derived: sum of 3 quarters · filed 2022-03-21 | -$234.00K 10-K · filed 2022-03-21 |
| 2019-09-30 | -$352.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$512.00K derived: sum of 2 quarters · filed 2020-11-05 | -$223.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | -$160.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $129.00K 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | $289.00K 10-Q · filed 2020-05-20 | |||
| 2018-12-31 | $297.00K 10-K · filed 2021-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |